Literature DB >> 11594824

A new, chiral bis-benzothiazine ligand.

M Harmata1, S K Ghosh.   

Abstract

[reaction: see text]. The synthesis and application of a new, chiral bis-benzothiazine ligand are described.

Entities:  

Year:  2001        PMID： 11594824     DOI： 10.1021/ol016546n

Source DB:  PubMed          Journal:  Org Lett        ISSN： 1523-7052            Impact factor:   6.005


  6 in total

1.  Preparation of S-2-halophenyl-2,1-benzothiazines.

Authors:  Aswin Garimalla; Michael Harmata
Journal:  Tetrahedron       Date:  2021-02-10       Impact factor: 2.457

Review 2.  Synthesis and Transformations of NH-Sulfoximines.

Authors:  Michael Andresini; Arianna Tota; Leonardo Degennaro; James A Bull; Renzo Luisi
Journal:  Chemistry       Date:  2021-10-13       Impact factor: 5.020

3.  Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates.

Authors:  Juan Alberto Sirvent; Ulrich Lücking
Journal:  ChemMedChem       Date:  2017-03-22       Impact factor: 3.466

4.  N-Arylation of NH-Sulfoximines via Dual Nickel Photocatalysis.

Authors:  Alexander Wimmer; Burkhard König
Journal:  Org Lett       Date:  2019-04-02       Impact factor: 6.005

5.  Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.

Authors:  Ulrich Lücking; Arne Scholz; Philip Lienau; Gerhard Siemeister; Dirk Kosemund; Rolf Bohlmann; Hans Briem; Ildiko Terebesi; Kirstin Meyer; Katja Prelle; Karsten Denner; Ulf Bömer; Martina Schäfer; Knut Eis; Ray Valencia; Stuart Ince; Franz von Nussbaum; Dominik Mumberg; Karl Ziegelbauer; Bert Klebl; Axel Choidas; Peter Nussbaumer; Matthias Baumann; Carsten Schultz-Fademrecht; Gerd Rühter; Jan Eickhoff; Michael Brands
Journal:  ChemMedChem       Date:  2017-10-16       Impact factor: 3.466

6.  Visible-Light-Mediated Photoredox-Catalyzed N-Arylation of NH-Sulfoximines with Electron-Rich Arenes.

Authors:  Alexander Wimmer; Burkhard König
Journal:  Adv Synth Catal       Date:  2018-08-02       Impact factor: 5.837
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.